MDS on Wednesday announced that Ricerca Biosciences has agreed to acquire its clinical trial services business for $45 million and some minority equity interests. MDS said the sale of the unit will complete its divestitures plan and allow the company to focus on Nordion, its medical isotope business.

Full Story:

Related Summaries